Abbrecht, P H and Littell, J K. 1972. Plasma erythropoietin in men and mice during acclimatization to different altitude. J Appl Physiol 32:54–8.CrossRefGoogle Scholar

Adachi, M, Cossman, J, Longo, D, Croce, C M, and Tsujimoto, Y. 1989. Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:2771–4.CrossRefGoogle ScholarPubMed

Adams, J, Palombella, V J, Sausville, E A, Johnson, J, Destree, A, Lazarus, D D, Maas, J, Pien, C S, Prakash, S, and Elliott, P J. 1999. Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Res 59:2615–22.Google ScholarPubMed

Adams, J M. 2003. Ways of dying: multiple pathways to apoptosis. Genes Dev 17:2481–95.CrossRefGoogle Scholar

Adams, J M, Harris, A W, Pinkert, C A, Corcoran, L M, Alexander, W S, Cory, S, Palmiter, R D, and Brinster, R L. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533–8.CrossRefGoogle ScholarPubMed

Adams, M D, Celniker, S E, Holt, R A, Evans, C A, Gocayne, J D, Amanatides, P G, Scherer, S E, Li, P W, Hoskins, R A, Galle, R F. 2000. The genome sequence of Drosophila melanogaster. Science 287:2185–95.CrossRefGoogle ScholarPubMed

Adler, I. 1912. Primary Malignant Growths of the Lungs and Bronchi. New York: Longmans, Green.Google Scholar

Adnane, J, Jackson, R J, Nicosia, S V, Cantor, A B, Pledger, W J, and Sebti, S M. 2000. Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene 19:5338–47.CrossRefGoogle Scholar

Advisory Committee to the Surgeon General. 1964. Smoking and Health. US Public Health Service Publication 1103, Washington, DC: US Dept Health, Education and Welfare.

Alberti, L, Carniti, C, Miranda, C, Roccato, E, Pierotti, M A. 2003. RET and NTRK1 proto-oncogenes in human diseases. J Cell Physiol 195:168–86.CrossRefGoogle ScholarPubMed

Al-Dewachi, H S, Appleton, D R, Watson, A J, and Wright, N A. 1979. Variation in the cell cycle time in the crypts of Lieberkuhn of the mouse. Virchows Arch B Cell Pathol Incl Mol Pathol 31:37–44.CrossRefGoogle ScholarPubMed

Al-Dewachi, H S, Wright, N A, Appleton, D R, and Watson, A J. 1974. The cell cycle time in the rat jejunal mucosa. Cell Tissue Kinet 7:587–94.Google ScholarPubMed

Al-Dewachi, H S, Wright, N A, Appleton, D R, and Watson, A J. 1975. Cell population kinetics in the mouse jejunal crypt. Virchows Arch B Cell Pathol 18:225–42.Google ScholarPubMed

Al-Dewachi, H S, Wright, N A, Appleton, D R, and Watson, A J 1977. The effect of a single injection of hydroxyurea on cell population kinetics in the small bowel mucosa of the rat. Cell Tissue Kinet 10:203–13.Google ScholarPubMed

Al-Dewachi, H S, Wright, N A, Appleton, D R, and Watson, A J 1980. The effect of a single injection of cytosine arabinoside on cell population kinetics in the mouse jejunal crypt. Virchows Arch B Cell Pathol Incl Mol Pathol 34:299–309.CrossRefGoogle ScholarPubMed

Alexander, W S, Adams, J M, and Cory, S. 1989. Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Mol Cell Biol 9:67–73.CrossRefGoogle Scholar

Allegra C J. 1990. Antifolates. In: Chabner, B A and Collins, J M (eds.). Cancer Chemotherapy, pp. 110–53. Philadelphia, PA: JB Lippincott.Google Scholar

Almoguera, C, Shibata, D, Forrester, K, Martin, J, Arnheim, N, and Perucho, M. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549–54.CrossRefGoogle ScholarPubMed

Al-Mulla, F, Going, J J, Sowden, E T, Winter, A, Pickford, I R, and Birnie, G D. 1998. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol 185:130–8.3.0.CO;2-M>CrossRefGoogle ScholarPubMed

Alpert, M E, Hutt, M S, and Davidson, C S. 1968. Hepatoma in Uganda A study in geographic pathology. Lancet I:1265–7.CrossRefGoogle Scholar

Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. 1994. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029–35.CrossRef

Alt, J R, Gladden, A B, and Diehl, J A. 2002. p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 277:8517–23.CrossRefGoogle ScholarPubMed

Alvarez, O A, Carmichael, D F, and Declerck, Y A. 1990. Inhibition of collagenolytic activity and metastasis by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82:589–95.CrossRefGoogle ScholarPubMed

American Cancer Society 1996 Advisory Committee on Diet, Nutrition, and Cancer Prevention. 1996. Guidelines on diet, nutrition, and cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 46:325–41.

American Cancer Society. 2005. Cancer Facts & Figures 2005. http://www.cancerorg/statistics.

Ames, B N and Gold, L S. 2000. Paracelsus to parascience: the environmental cancer distraction. Mutat Res 447:3–13.CrossRefGoogle ScholarPubMed

Ames, B N, Magaw, R, Gold, L S. 1987. Ranking possible carcinogenic hazards. Science 236:271–80.CrossRefGoogle ScholarPubMed

Anaissie, E J, Vartivarian, S, Bodey, G P, Legrand, C, Kantarjian, H, Abi-Said, D, Karl, C, and Vadhan-Raj, S. 1996. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (escherichia coli-derived in cancer patients with fever and neutropenia. Am J Med 100:17–23.CrossRefGoogle ScholarPubMed

Anderson, K C, Bates, M P, Slaughenhoupt, B L, Pinkus, G S, Schlossman, S F, and Nadler, L M. 1984. Expression of human b cell-associated antigens on leukemias and lymphomas: A model of human b cell differentiation. Blood 63:1424–33.Google Scholar

Anderson, T. 1994. Palaeopathology: More than just dry bones. Proc R Coll Physicians Edinb 24:554–80.Google ScholarPubMed

Anderson, T J, Battersby, S, King, R J B, McPherson, K, and Going, J J. 1989. Oral contraceptive use influences resting breast proliferation. Human Pathology 20:1139–44.CrossRefGoogle ScholarPubMed

Anderson, T J, Ferguson, D J, and Raab, G M. 1982. Cell turnover in the “resting” human breast: Influence of parity, contraceptive pill, age and laterality. Br J Cancer 46:376–82.CrossRefGoogle ScholarPubMed

Andrews, P W. 2002. From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 357:405–17.CrossRefGoogle ScholarPubMed

Anonymous. 1994. A 44 year campaign, but the epidemic is growing. BMJ 309: Number 6960, unnumbered contents page (8 October 1994).

Anthony, M, Williams, J K, and Dunn, B K. 2001. What would be the properties of an ideal SERM? Annals of the New York Academy of Sciences 949:261–78.CrossRefGoogle ScholarPubMed

Aoki, T, Takeda, S, Yanagisawa, A, Kato, Y, Ajioka, Y, Watanabe, H, Kudo, S, and Nakamura, Y. 1994. APC and p53 mutations in de novo colorectal adenocarcinomas. Hum Mutat 3:342–6.CrossRefGoogle ScholarPubMed

ATAC Trialists' Group. 2005. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60–2.CrossRef

Aragane, Y, Kulms, D, Metze, D, Wilkes, G, Poppelmann, B, Luger, T A, and Schwarz, T. 1998. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol 140:171–82.CrossRefGoogle ScholarPubMed

Armstrong, B K. 1984. Melanoma of the skin. Br Med Bull 40:346–50.CrossRefGoogle ScholarPubMed

Armstrong, B K. 1988. Epidemiology of malignant melanoma: Intermittent or total accumulated exposure to the sun?J Dermatol Surg Oncol 14:835–49.CrossRefGoogle ScholarPubMed

Armstrong P B. 1984. Invasiveness of non-malignant cells. In Invasion, Experimental and Clinical Implications, Mareel, M M and Calman, K C, eds, pp. 126–167. Oxford, UK: Oxford University Press.Google Scholar

Ashkenazi, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420–30.CrossRefGoogle ScholarPubMed

Ashworth, T R. 1869. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 14:146–7.Google Scholar

Assoian, R K and Zhu, X. 1997. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol 9:93–8.CrossRefGoogle ScholarPubMed

Aszterbaum, M, Epstein, J, Oro, A, Douglas, V, LeBoit, P E, Scott, M P, and Epstein, E H Jr. 1999. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285–91.CrossRefGoogle ScholarPubMed

Ault, J G, Cole, R W, Jensen, C G, Jensen, L C, Bachert, L A, and Rieder, C L. 1995. Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res 55:792–8.Google ScholarPubMed

Bach, P B, Kattan, M W, Thornquist, M D, Kris, M G, Tate, R C, Barnett, M J, Hsieh, L J, and Begg, C B. 2003. Variations in lung cancer risk among smokers. J Natl Cancer Inst 95:470–8.CrossRefGoogle ScholarPubMed

Bader, J P. 1972. Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J Virol 10:267–76.Google ScholarPubMed

Bagshawe, K D. 1992. Choriocarcinoma: A model for tumour markers. Acta Oncol 31:99–106.CrossRefGoogle ScholarPubMed

Baker, S J, Markowitz, S, Fearon, E R, Willson, J K, and Vogelstein, B. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–15.CrossRefGoogle ScholarPubMed

Baldus, C D, Tanner, S M, Ruppert, A S, Whitman, S P, Archer, K J, Marcucci, G, Caligiuri, M A, Carroll, A J, Vardiman, J W, Powell, B L. 2003. BAALC expression predicts clinical outcome of de vovo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B study. Blood 102:1613–8.CrossRefGoogle Scholar

Bale A E and Brown S J. 2001. Etiology of cancer: cancer genetics. In: DeVita, V T, Hellman, S, and Rosenberg, S A (eds.). Cancer, Principles and Practice of Oncology, 6th ed., pp. 207–17. Philadelphia, PA: Lippincott Williams & Wilkins.Google Scholar

Balendran, A, Casamayor, A, Deak, M, Paterson, A, Gaffney, P, Currie, R, Downes, C P, and Alessi, D R. 1999. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol 9:393–404.CrossRefGoogle ScholarPubMed

Barber, H R K and Brunschwig, A. 1968. Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration. Cancer 22:949–55.3.0.CO;2-7>CrossRefGoogle ScholarPubMed

Bargmann, C I, Hung, M C, and Weinberg, R A. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649–57.CrossRefGoogle ScholarPubMed

Barker, N, Morin, P J, and Clevers, H. 2000. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 77:1–24.Google ScholarPubMed

Barradell, L B and Faulds, D. 1994. Cyproterone A review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs Aging 5:59–80.CrossRefGoogle ScholarPubMed

Barratt-Fornell, A, Drewnowski, A. 2002. The taste of health: nature's bitter gifts. Nutr Today 37:144–50.CrossRefGoogle ScholarPubMed

Bar-Sagi, D and Feramisco, J R. 1985. Micro-injection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42:841–8.CrossRefGoogle Scholar

Bartsch, H, Ohshima, H, Pignatelli, B, and Calmels, S. 1992. Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 2:272–7.CrossRefGoogle ScholarPubMed

Baselga, J, Pfister, D, Cooper, M R, Cohen, R, Burtness, B, Bos, M, D'Andrea, G, Seidman, A, Norton, L, Gunnett, K. 2000. Phase I studies of anti-epidermal growth factor receptor chimeric antibody c225 alone and in combination with cisplatin. J Clin Oncol 18:904–14.CrossRefGoogle ScholarPubMed

Baskaran, R, Dahmus, M E, and Wang, J Y J. 1993. Tyrosine phosphorylation of mammalian RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci USA 90:11167–71.CrossRefGoogle Scholar

Bates, C M, Kharzai, S, Erwin, T, Rossant, J, and Parada, L F. 2000. Role of N-myc in the developing mouse kidney. Dev Biol 222:317–25.CrossRefGoogle ScholarPubMed

Batzdorf U, Black K L, and Selch M T. 1990. Neoplasms of the nervous system. In: Haskell, C M (ed.). Cancer Treatment, 3rd ed., pp. 436–68. Philadelphia, PA: WB Saunders.Google Scholar

Batzer, A G, Blaikie, P, Nelson, K, Schlessinger, J, and Margolis, B. 1995. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol 15:4403–9.CrossRefGoogle ScholarPubMed

Baum, M. 1976. The curability of breast cancer. Br Med J 1:439–42.CrossRefGoogle ScholarPubMed

Baumann, P C and Harshbarger, J C. 1995. Decline in liver neoplasms in wild brown bullhead catfish after coking plant closes and environmental PAHs plummet. Environ Health Perspect 103:168–70.CrossRefGoogle ScholarPubMed

Baxevanis, C N, Sotiropoulou, P A, Sotiriadou, N N, and Papamichail, M. 2004. Immunobiology of HER-2/ neu oncoprotein and its potential application in cancer immunotherapy. Cancer Immunol Immunother 53:166–75.CrossRefGoogle ScholarPubMed

Bayreuther, K. 1960. Chromosomes in primary neoplastic growth. Nature 186:6–9.CrossRefGoogle ScholarPubMed

Beckman, K B and Ames, B N. 1997. Oxidative decay of DNA. J Biol Chem 272:19633–6.CrossRefGoogle ScholarPubMed

Beirut, L J, Dinwiddie, S H, Begleiter, H, Crowe, R R, Hesselbrock, V, Nurnberger, J I Jr, Porjesz, B, Schuckit, M A, and Reich, T. 1998. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 55:982–8.CrossRefGoogle Scholar

Bell B. 1794. A Treatise on the Hydrocele or Sarcocele, or Cancer and Other Disease of the Testes. Edinburgh.

Bellacosa, A, Testa, J R, Staal, S P, and Tsichlis, P N. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274–7.CrossRefGoogle ScholarPubMed

Bender R A, Hamel E, and Hande K R. 1990. Plant alkaloids. In: Chabner, B A and Collins, J M (eds.). Cancer Chemotherapy, pp. 253–75. Philadelphia, PA: JB Lippincott.Google Scholar

Beral, V, Peterman, T A, Berkelman, R L, and Jaffe, H W. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?Lancet 335:123–8.CrossRefGoogle ScholarPubMed

Berchuck, A, Kamel, A, Whitaker, R, Kerns, B, Olt, G, Kinney, R, Soper, J T, Dodge, R, Clarke-Pearson, D L, Marks, P. 1990. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087–91.Google ScholarPubMed

Berek J S and Hacker N F. 1990. Ovary and fallopian tubes. In: Haskell, C M (ed.). Cancer Treatment, 3rd ed., pp. 295–325. Philadelphia, PA: WB Saunders.Google Scholar

Berenblum, I and Shubik, P. 1947. The role of croton oil application associated with a single painting of a carcinogen in tumour induction of the mouse's skin. Br J Cancer 1:379–83.CrossRefGoogle Scholar

Berenson J R and Gale R P. 1990. Acute lymphoblastic leukemia. In: Haskell, C M (ed.). Cancer Treatment, 3rd ed., pp. 606–20. Philadelphia, PA: WB Saunders.Google Scholar

Berkowitz R S and Goldstein D P. 1990. Gestational trophoblastic neoplasia. In: Haskell, C M (ed.). Cancer Treatment, 3rd ed., pp. 366–72. Philadelphia, PA: WB Saunders.Google Scholar

Berman M L and Berek J S. 1990. Uterine corpus. In: Haskell, C M (ed.). Cancer Treatment, 3rd ed, pp. 338–51. Philadelphia, PA: WB Saunders.Google Scholar

Beukers, R and Berends, W. 1960. Isolation and identification of the irradiation product of thymine. Biochim Biophys Acta 41:550–1.CrossRefGoogle ScholarPubMed

Beutler, B and Cerani, A. 1986. Cachectic and tumor necrosis factors as two sides of the same biological coin. Nature 320:584–8.CrossRefGoogle ScholarPubMed

Bevona, C and Sober, A J. 2002. Melanoma incidence trends. Dermatol Clin 20:589–95.CrossRefGoogle ScholarPubMed

Biggs, J, Hersperger, E, Steeg, P S, Liotta, L A, and Shearn, A. 1990. A Drosophila gene that is homologous to a mammalian gene associated with tumor metastasis codes for a nucleoside diphosphate kinase. Cell 63:933–40.CrossRefGoogle ScholarPubMed

Biggs, P M. 2001. The history and biology of Mareks disease virus. Curr Top Microbiol Immunol 255:1–24.Google Scholar

Bingham, C A. 1978. The cell cycle and cancer chemotherapy. Am J Nurs 78:1201–5.CrossRefGoogle ScholarPubMed

Bingham, S A, Day, N E, Luben, R, Ferrari, P, Slimani, N, Norat, T, Clavel-Chapelon, F, Kesse, E, Nieters, A, Boeing, H. 2003. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into cancer and nutrition (EPIC): an observational study. Lancet 361:1496–1501.CrossRefGoogle ScholarPubMed

Binns, A N. 2002. T-DNA of Agrobacterium tumefaciens: 25 years and counting. Trends Plant Sci 7:231–3.CrossRefGoogle ScholarPubMed

Birner, P, Oberhuber, G, Stani, J, Reithofer, C, Samonigg, H, Hausmaninger, H, Kubista, E, Kwasny, W, Kandioler-Eckersberger, D, Gnant, M. 2001. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7:1669–75.Google ScholarPubMed

Bister, K and Jansen, H W. 1986. Oncogenes in retroviruses and cells: Biochemistry and molecular genetics. Adv Cancer Res 47:99–188.CrossRefGoogle ScholarPubMed

Bittner, J J. 1936. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162.CrossRefGoogle ScholarPubMed

Bittner, J J. 1937. Mammary tumors in mice in relation to nursing. Am J Cancer 30:530–8.CrossRefGoogle Scholar

Bjorge, J D, Jakymiw, A and Fujita, D J. 2000. Selected glimpses into the activation and function of Src kinase. Oncogene 19:5620–35.CrossRefGoogle ScholarPubMed

Bjorkoy, G, Overvatn, A, Diaz-Meco, M T, Moscat, J, and Johansen, T. 1995. Evidence for a bifurcation of the mitogenic signaling pathway activated by Ras and phosphatidylcholine-hydrolyzing phospholipase C. J Biol Chem 270:21299–21306.Google ScholarPubMed

Blain, S W, Montalvo, E, and Massague, J. 1997. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem 272:25863–72.CrossRefGoogle ScholarPubMed

Blakeslee, A F. 1934. New Jimson weeds from old chromosomes. J Hered 25:80–108.CrossRefGoogle Scholar

Blaney, S M, Bernstein, M, Neville, K, Ginsberg, J, Kitchen, B, Horton, T, Berg, S L, Krailo, M, and Adamson, P C. 2004. Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: A children's oncology group study (advl0015). J Clin Oncol 22:4752–7.CrossRefGoogle Scholar

Blasco, M A, Lee, H W, Hande, M P, Samper, E, Lansdorp, P M, DePinho, R A, and Greider, C W. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25–34.CrossRefGoogle ScholarPubMed

Blezinger, P, Wang, J, Gondo, M, Quezada, A, Mehrens, D, French, M, Singhal, A, Sullivan, S, Rolland, A, Ralston, R, and Min, W. 1999. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 17:343–8.CrossRefGoogle ScholarPubMed

Blount, W P. 1961. Turkey “X” disease. J Br Turkey Fed 9:522–8.Google Scholar

Blume-Jensen, P and Hunter, T. 2001. Oncogenic kinase signalling. Nature 411:355–65.CrossRefGoogle ScholarPubMed

Bobrovnikova-Marjon, E V, Marjon, P L, Barbash, O, Vander Jagt, D L, and Abcouwer, S F. 2004. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/cxcl8 is highly responsive to ambient glutamine availability: Role of nuclear factor-kappab and activating protein-1. Cancer Res 64:4858–69.CrossRefGoogle ScholarPubMed

Boccardo, F, Bruzzi, P, Rubagotti, A, Nicolo, G U, and Rosso, R. 1981. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 38:281–5.CrossRefGoogle ScholarPubMed

Bocci, G, Nicolaou, K C, and Kerbel, R S. 2002. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62:6938–43.Google ScholarPubMed

Bodmer, W F, Bailey, C J, Bodmer, J, Bussey, H J, Ellis, A, Gorman, P, Lucibello, F C, Murday, V A, Rider, S H, Scambler, P. 1987. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614.CrossRefGoogle ScholarPubMed

Bodnar, A G, Ouellette, M, Frolkis, M, Holt, S E, Chiu, C P, Morin, G B, Harley, C B, Shay, J W, Lichtsteiner, S, and Wright, W E. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–52.CrossRefGoogle ScholarPubMed

Boffetta, P. 2002. Involuntary smoking and lung cancer. Scand J Work Environ Health 28, Suppl 2:30–40.Google ScholarPubMed

Bogenrieder, T and Herlyn, M. 2003. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22:6524–36.CrossRefGoogle ScholarPubMed

Boice, J D Jr, Greene, M H, Killen, J Y, Ellenberg, S S, Keehn, R J, McFadden, E, Chen, T T, and Fraumeni, J F Jr. 1983. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine methyl-CCNU. N Engl J Med 309:1079–84.CrossRefGoogle ScholarPubMed

Borthwick, N J, Bofill, M, Hassan, I, Panayiotidis, P, Janossy, G, Salmon, M, and Akbar, A N. 1996. Factors that influence activated CD8+ T-cell apoptosis in patients with acute herpesvirus infections: Loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression. Immunology 88:508–15.Google ScholarPubMed

Borucinska, J D, Harshbarger, J C, Reimschuessel, R, and Bogicevic, T. 2004. Gingival neoplasms in a captive sand tiger shark, Carcharias taurus (Rafinesque), and a wild-caught blue shark, Prionace glauca (L). J Fish Diseases 27:185–91.CrossRefGoogle Scholar

Bosari, S, Lee, A K, DeLellis, R A, Wiley, B D, Heatley, G J, and Silverman, M L. 1992. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–61.CrossRefGoogle ScholarPubMed

Bouroncle, B A. 1994. Thirty-five years in the progress of hairy cell leukemia. Leuk Lymphoma 14 (Suppl 1):1–12.Google ScholarPubMed

Boveri, T. 1907. Zellen-Studien. Heft 6. Die Entwicklung dispermer Seeigel-Eier. Ein Beitrag zur Befruchtungslehre und zur Theorie des Kerns. Jena: Gustav Fischer.Google Scholar

Boveri, T. 1914. Zur Frage der Erstehung Maligner Tumoren. Jena: Gustav Fischer (English translation by M Boveri). 1929. The Origin of Malignant Tumors. Baltimore, MD: Williams and Wilkins).Google Scholar

Bowen, I D and Bowen, S M. 1990. Programmed Cell Death in Tumors and Tissues. New York: Chapman and Hall.Google Scholar

Bowman, T, Broome, M A, Sinibaldi, D, Wharton, W, Pledger, W J, Sedivy, J M, Irby, R, Yeatman, T, Courtneidge, S A, and Jove, R. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 98:7319–24.CrossRefGoogle ScholarPubMed

Boyle, P, Zaridze, D G, and Smans, M. 1985. Descriptive epidemiology of colorectal cancer. Int J Cancer 36:9–18.CrossRefGoogle ScholarPubMed

Brandom, W F, Saccomanno, G, Archer, V E, Archer, P G, and Bloom, A D. 1978. Chromosome aberrations as a biological dose-response indicator of radiation exposure in uranium miners. Rad Res 76:59–171.CrossRefGoogle ScholarPubMed

Braun, A C. 1956. The activation of two growth-substance systems accompanying the conversion of normal to tumor cells in crown gall. Cancer Res 16:53–6.Google ScholarPubMed

Braun A C. 1972. The usefulness of plant tumor systems for studying the basic cellular mechanisms that underlie neoplastic growth generally. In: Harris, R, Allin, P, and Viza, D (eds.). Cell Differentiation, pp. 115–18. Copenhagen: Munksgaard.Google Scholar

Braun, A C. 1974. The Biology of Cancer. Reading, MA: Addison-Wesley Publishing Company.Google Scholar

Braun, A C. 1981. An epigenetic model for the origin of cancer. Q Rev Biol 56:33–60.CrossRefGoogle ScholarPubMed

Breinholt, V, Hendricks, J, Pereira, C, Arbogast, D, and Bailey, G. 1995. Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout. Cancer Res 55:57–62.Google ScholarPubMed

Brentnall, T A, Haggitt, R C, Rabinovitch, P S, Kimmey, M B, Bronner, M P, Levine, D S, Kowdley, K V, Stevens, A C, Crispin, D A, Emond, M. 1996. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110:331–8.CrossRefGoogle ScholarPubMed

Bridges, C B. 1916. Non-disjunction as proof of the chromosome theory of heredity. Genetics 1:107–63.Google ScholarPubMed

Briggs, R and King, T J. 1952. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA 38:455–63.CrossRefGoogle ScholarPubMed

Brinster, R. 1993. Stem cells and transgenic mice in the study of development. Int J Dev Biol 37:89–99.Google Scholar

Brinster, R L. 1974. Effects of cells transferred into the mouse blastocyst on subsequent development. J Exp Med 140:1049–56.CrossRefGoogle Scholar

Brinster, R L, Chen, H Y, Messing, A A, Dyke, T, Levine, A J, and Palmiter, R D. 1984. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 37:367–79.CrossRefGoogle ScholarPubMed

Bromberg, J and Darnell, J E Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468–73.CrossRefGoogle ScholarPubMed

Bromley, M, Rew, D, Becciolini, A, Balzi, M, Chadwick, C, Hewitt, D, Li, Y Q, and Potten, C S. 1996. A comnparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur J Histochem 40:89–100.Google ScholarPubMed

Brown, D R, Fife, K H, Wheeler, C M, Koutsky, L A, Lupinacci, L M, Railkar, R, Suhr, G, Barr, E, Dicello, A, Li, W. 2004. Early assessment of the efficacy of a human papillomavirus type 16 virus-like particle vaccine. Vaccine 22:2936–42.CrossRefGoogle ScholarPubMed

Bucher, N L R and Malt, R A. 1971. Regeneration of the Liver and Kidney. Boston, MA: Little, Brown.Google Scholar

Buchkovich, K, Duffy, L A, and Harlow, E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.CrossRefGoogle ScholarPubMed

Buday, L and Downward, J. 1993. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611–20.CrossRefGoogle ScholarPubMed

Budillon, A, Cereseto, A, Kondrashin, A, Nesterova, M, Merlo, G, Clair, T, and Cho-Chung, Y S. 1995. Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts. Proc Natl Acad Sci USA 92:10634–8.CrossRefGoogle ScholarPubMed

Bullough, W S. 1962. The control of mitotic activity in adult mammalian tissues. Biol Rev 37:301–42.CrossRefGoogle ScholarPubMed

Bunn P A Jr and Ridgway E C. 1993. Paraneoplastic syndromes. In: DeVita, V T Jr., Hellman, S., and Rosenberg, S A (eds.). Cancer Principles and Practice of Oncology, 4th ed., pp. 2026–71. Philadelphia, PA: JB Lippincott.Google Scholar

Burke, T G, Morin, M J, Sartorelli, A C, Lane, P E, and Tritton, T R. 1987. Function of the anthracycline amino group in cellular transport and cytotoxicity. Mol Pharmacol 31:552–6.Google ScholarPubMed

Burkitt, D P. 1958. A sarcoma involving the jaws of African children. Br J Surg 46:218–25.CrossRefGoogle ScholarPubMed

Burkitt, D P. 1971. Epidemiology of cancer of the colon and rectum. Cancer 28:3–13.3.0.CO;2-N>CrossRefGoogle ScholarPubMed

Burkitt, D P. 1975. Large-bowel cancer: An epidemiological jigsaw puzzle. J Natl Cancer Inst 54:3–6.CrossRefGoogle ScholarPubMed

Burmer, G C and Loeb, L A. 1989. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 86:2403–7.CrossRefGoogle ScholarPubMed

Butel, J S and Lednicky, J A. 1999. Cell and molecular biology of simian virus 40: implications or human infections and disease. J Natl Cancer Inst 91:119–34.CrossRefGoogle ScholarPubMed

Buters, J T, Sakai, S, Richter, T, Pineau, T, Alexander, D L, Savas, U, Doehmer, J, Ward, J M, Jefcoate, C R, and Gonzalez, F J. 1999. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96:1977–82.CrossRefGoogle ScholarPubMed

Butler, T P and Gullino, P M. 1975. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35:512–16.Google ScholarPubMed

Butlin, H J. 1892. Cancer of the scrotum in chimney-sweeps and others: II. Why foreign sweeps do not suffer from scrotal cancer. Br Med J 2:1–6.CrossRefGoogle Scholar

Butrum, R R, Clifford, C K, and Lanza, E. 1988. NCI dietary guidelines: Rationale. Am J Clin Nutr 48:888–95.CrossRefGoogle ScholarPubMed

Byers, T, Nestle, M, McTiernan, A, Doyle, C, Currie-Williams, A, Gansler, T, and Thun, M. 2002. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk for cancer with healthy food choices and physical activity. CA Cancer J Clin 52:92–119.CrossRefGoogle ScholarPubMed

Calabresi P and Parks R E Jr. 1980. Antiproliferative agents and drugs used for immunosuppression. In: Gilman, A G, Goodman, L S, and Gilman, A (eds.). The Pharmacological Basis of Therapeutics, pp. 1256–1313. New York: Macmillan.Google Scholar

Calabresi, P and Schein, P S (eds.). 1993. Medical Oncology: Basic Principles and Clinical Management of Cancer. New York: McGraw-Hill.Google Scholar

Calabresi, P and Welch, A D. 1962. Chemotherapy of neoplastic diseases. Annu Rev Med 13:147–202.CrossRefGoogle ScholarPubMed

Calman K C. 1992. Cachexia. In: McGee, J O'D, Isaacson, P G, and Wright, N A (eds.). Oxford Textbook of Pathology, vol 1, pp. 715–17. Oxford, UK: Oxford University Press.Google Scholar

Cameron, I L, Hardman, W E, and Skehan, P. 1990. Regulation of growth in normal and neoplastic cell populations by a tissue sizer mechanism: Therapeutic implications. Prog Clin Biol Res 354A:61–79.Google ScholarPubMed

Campen, C A, Jordan, V C, and Gorski, J. 1985. Opposing biological actions of antiestrogens in vitro and in vivo: Induction of progesterone receptor in the rat and mouse uterus. Endocrinology 116:2327–36.CrossRefGoogle ScholarPubMed

Carlson, D B and Perdew, G H. 2002. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 16:317–25.CrossRefGoogle Scholar

Carroll, K K and Khor, H T. 1975. Dietary fat in relation to tumorigenesis. Prog Biochem Pharmacol 10:308–53.Google ScholarPubMed

Carson, D A, Kaye, J, and Wasson, D B. 1980. Differences in deoxyadenosine metabolism in human and mouse lymphocytes. J Immunol 124:8–12.Google ScholarPubMed

Carson, D A, Wasson, D B, Kaye, J, Ullman, B, Martin, D W Jr, Robins, R K, and Montgomery, J A. 1980. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc Natl Acad Sci USA 77:6865–9.CrossRefGoogle ScholarPubMed

Case, R A. 1969. Some environmental carcinogens. Proc R Soc Med 62:1061–6.Google ScholarPubMed

Case, R A M and Hosker, M E. 1954. Tumours of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Br J Prev Soc Med 8:39–50.Google ScholarPubMed

Case, R A, Hosker, M E, McDonald, D B, and Pearson, J T. 1954. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry: Part I. The role of aniline, benzidine, alpha-naphthylamine and beta-napthylamine. Br J Ind Med 11: 75–104.Google Scholar

Cerhan, J R, Potter, J D, Gilmore, J M, Janney, C A, Kushi, L H, Lazovich, D, Anderson, K E, Sellers, T A, and Folsom, A R. 2004. Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa women's health study cohort. Cancer Epidemiol Biomarkers Prev 13:1114–20.Google ScholarPubMed

Cerutti, P. 1985. Prooxidant states and tumor promotion. Science 227:375–81.CrossRefGoogle ScholarPubMed

Chabner B A. 1990a. Cytidine analogues. In: Chabner, B A and Collins, J M (eds.). Cancer Chemotherapy, pp. 154–79. Philadelphia, PA: JB Lippincott.Google Scholar

Chabner B A. 1990b. Bleomycin. In: Chabner, B A and Collins, J M (eds.). Cancer Chemotherapy, pp. 341–55. Philadelphia, PA: JB Lippincott.Google Scholar

Chabner B A. 1990c. Clinical strategies for cancer treatment: The role of drugs. In: Chabner, B A and Collins, J M (eds.). Cancer Chemotherapy, pp. 1–15. Philadelphia, PA: JB Lippincott.Google Scholar

Chang, R L, Huang, M T, Wood, A W, Wong, C Q, Newmark, H L, Yagi, H, Sayer, J M, Jerind, D M, and Conney, A H. 1985. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo(a)pyrene and ±-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene on mouse skin and in the newborn mouse. Carcinogenesis 6:1127–33.CrossRefGoogle Scholar

Chang, S, Khoo, C, and DePinho, R A. 2001. Modeling chromosomal instability and epithelial carinogenesis in the telomerase-deficient mouse. Semin Cancer Biol 11:227–39.CrossRefGoogle Scholar

Chaplin, D J and Trotter, M J. 1990. The nature of tumor hypoxia: Implications for therapy. Prog Clin Biol Res 354B:81–92.Google Scholar

Charbit, A, Malaise, E P, and Tubiana, M. 1971. Relation between the pathological nature and the growth rate of human tumors. Eur J Cancer 7:307–15.CrossRefGoogle ScholarPubMed

Chardin, P, Camonis, J H, Gale, N W, Aelst, L, Schlessinger, J, Wigler, M H, and Bar-Sagi, D. 1993. Human Sos1: A guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260:1338–43.CrossRefGoogle ScholarPubMed

Charlson, M E. 1985. Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet 160:393–9.Google ScholarPubMed

Charron, J, Malynn, B A, Fisher, P, Stewart, V, Jeannotte, L, Goff, S P, Robertson, E J, and Alt, F W. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6:2248–57.CrossRefGoogle ScholarPubMed

Chau, B N, Borges, H L, Chen, T T, Masselli, A, Hunton, I C, and Wang, J Y. 2002. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 4:757–65.CrossRefGoogle ScholarPubMed

Chau, B N and Wang, J Y. 2003. Coordinated regulation of life and death by RB. Nat Rev Cancer 3:130–8.CrossRefGoogle ScholarPubMed

Chen, L L, Trent, J C, Wu, E F, Fuller, G N, Ramdas, L, Zhang, W, Raymond, A K, Prieto, V G, Oyedeji, C O, Hunt, K K. 2004. A missense mutation in kit kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64:5913–19.CrossRefGoogle ScholarPubMed

Chin, K V, Pastan, I, and Gottesman, M M. 1993. Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157–80.CrossRefGoogle ScholarPubMed

Chiu, R, Boyle, W J, Meek, J, Smeal, T, Hunter, T, and Karin, M. 1988. The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541–52.CrossRefGoogle ScholarPubMed

Chuang, T Y, Popecsh, A, Su, W P D, and Chute, C G. 1990. Basal cell carcinoma. J Am Acad Dermatol 22:413–17.CrossRefGoogle ScholarPubMed

Chumas, P, Tyagi, A, Livingston, J. 2001. Hydrocephalus – what's new? Arch Dis Child Fetal Neonatal Ed. 85:F149–54.CrossRefGoogle ScholarPubMed

Clarke, R, Lippman, M E, and Dickson, R B. 1990. Mechanisms of hormone and cytotoxic drug interactions in the development and treatment of breast cancer. Prog Clin Biol Res 322:243–78.Google ScholarPubMed

Cleary, M L, Smith, S D and Sklar, J. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19–28.CrossRefGoogle Scholar

Cleaver, J E. 1968. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218:652–6.CrossRefGoogle ScholarPubMed

Cleaver, J E. 1994. It was a good year for DNA repair. Cell 76:1–4.CrossRefGoogle ScholarPubMed

Cleaver, J E and Crowley, E. 2002. UV damage, DNA repair and skin carcinogenesis. Front Biosci 7:d1024–43.Google ScholarPubMed

Cleaver J E and Kraemer K H. 1989. Xeroderma pigmentosum. In: Scriver, C R, Beaudet, A L, Sly, W S, and Valle, D (eds.). The Metabolic Basis of Inherited Disease, 6th ed., pp. 2949–71. New York: McGraw-Hill.Google Scholar

Cohen, S M and Ellwein, L B. 1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res 51:6493–6505.Google ScholarPubMed

Collaborative Group on Hormonal Factors in Breast Cancer. 2002. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187–95.CrossRef

Colombo, N. 1994. Controversial issues in the management of early epithelial ovarian cancer: Conservative surgery and the role of adjuvant therapy. NIH Consensus Development Conference on Ovarian Cancer: Screening, Treatment, and Followup April 5–7, Bethesda, MD: NIH.Google Scholar

Coman, D R. 1944. Decreased mutual adhesiveness, a property of cells from squamous cell carcinomas. Cancer Res 4:625–9.Google Scholar

Conney, A H. 1982. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 42:4875–4917.Google ScholarPubMed

Conrad, R A, Dobyns, B M, and Sutow, W W. 1970. Thyroid neoplasia as a late effect of exposure to radioactive iodine in fallout. J Am Med Assoc 214:316–24.CrossRefGoogle Scholar

Cook, J W, Hewett, C L, and Hieger, I. 1933. The isolation of a cancer-producing hydrocarbon from coal tar Parts I, II, and III. J Chem Soc Issue 395–405.CrossRefGoogle Scholar

Cook, S J and McCormick, F. 1993. Inhibition by cAMP of Ras-dependent activation of RafScience 262:1069–72.CrossRefGoogle ScholarPubMed

Cooper, D Y, Levin, S S, Narrasimhulu, S, Rosenthal, O, and Estabrook, R W. 1965. Photochemical action spectrum of the terminal oxidase of mixed function oxidase systems. Science 147:400–2.CrossRefGoogle ScholarPubMed

Corcos, L and Lagadic-Gossmann, D. 2001. Gene induction by Phenobarbital: an update on an old question that receives key novel answers. Pharmacol Toxicol 89:113–22.CrossRefGoogle ScholarPubMed

Cornwell, M M, Tsuruo, T, Gottesman, M M, and Pastan, I. 1987. ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J 1:51–4.CrossRefGoogle ScholarPubMed

Cory, S, Vaux, D L, Strasser, A, Harris, A W, and Adams, J M. 1999. Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res 59(7 Suppl):1685s–1692s.Google ScholarPubMed

Cotran, R S, Kumar, V, and Robbins, S L. 1994. Pathological Basis of Cancer, 5th ed. Philadelphia, PA: WB Saunders.Google Scholar

Coultas, L and Strasser, A. 2003. The role of the Bcl-2 protein family in cancer. Semin Cancer Biol 13:115–23.CrossRefGoogle Scholar

Counts, J L, Sarmiento, J I, Harbison, M L, Downing, J C, McClain, R M, and Goodman, J L. 1996. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration. Carcinogenesis 17:1251–7.CrossRefGoogle ScholarPubMed

Courtneidge, S A. 2003. Cancer: Escape from inhibition. Nature 422:827–8.CrossRefGoogle ScholarPubMed

Coutard, H. 1932. Roentgenotherapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. Roentgenol Radium Ther 28:313–31.Google Scholar

Cox, A D and Der, C J. 2002. Ras family signaling: therapeutic targeting. Cancer Biol Ther. 1:599–606.CrossRefGoogle ScholarPubMed

Cox, A D and Der, C J. 2003. The dark side of Ras: regulation of apoptosis. Oncogene 22:8999–9006.CrossRefGoogle ScholarPubMed

Cox, E C. 1976. Bacterial mutator genes and the control of spontaneous mutation. Annu Rev Genet 10:135–56.CrossRefGoogle ScholarPubMed

Crum, C P. 2002. The beginning of the end for cervical cancer?N Engl J Med 347:1703–5.CrossRefGoogle ScholarPubMed

Culver, K, Cornetta, K, Morgan, R, Morecki, S, Aerbersold, T, Kasid, A, Lotv, M, Rosenberg, S A, Anderson, W F, and Blaese, R M. 1991. Lymphocyte as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci USA 88:3155–9.CrossRefGoogle ScholarPubMed

Cummings, S R, Eckert, S, Krueger, K A, Grady, D, Powles, T J, Cauley, J A, Norton, L, Nickelsen, T, Bjarnason, N H, Morrow, M. 1999. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281:2189–97.CrossRefGoogle ScholarPubMed

Cunningham, M and Matthews, H B. 1995. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. Toxicol Lett 82–83:9–14.CrossRefGoogle ScholarPubMed

Cunningham, D, Humblet, Y, Siena, S, Khayat, D, Bleiberg, H, Santoro, A, Bets, D, Mueser, M, Harstrick, A, Verslype, C. 2004. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–45.CrossRefGoogle ScholarPubMed

Curry, S J, Byers, T, and Hewitt, M. (eds). 2003. Cancer Prevention and Early Detection. Washington, DC: The National Academies Press.Google Scholar

Cushing, H and Wolback, S B. 1927. The transformation of a malignant paravertebral neuroblastoma into a benign ganglioneuroma. Am J Pathol 3:203–16.Google Scholar

Daenen, S, Vellenga, E, Dobbenburgh, O A, and Halie, M R. 1986. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood 67:559–61.Google Scholar

Dalla Favera, R, Bregni, M, Erikson, J, Patterson, D, Gallo, R C, and Croce, C M. 1982. Assignment of the c-myc oncogene to the region of chromosome 8 which is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79:7824–7.CrossRefGoogle Scholar

Davesa, S S, Grauman, D J, Blot, W J, Pennello, G, Hoover, R N, and Fraumeni, J F Jr. 1999. Atlas of Cancer Mortality in the United States, 1950–94. Washington, DC: US Govt Print Off (NIH) 99–4564.Google Scholar

Davidson, J R. 1934. Attempt to inhibit development of tar-carcinoma in mice: Preliminary note. Can Med Assoc J 31:486–7.Google ScholarPubMed

Davies, B R, Platt-Higgins, A M, Schmidt, G, and Rudland, P S. 1999. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats. Am J Pathol 155:303–14.CrossRefGoogle ScholarPubMed

Davies, H, Bignell, G R, Cox, C, Stephens, P, Edkins, S, Clegg, S, Teague, J, Woffendin, H, Garnett, M J, and Bottomley, W. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949–54.CrossRefGoogle ScholarPubMed

Davies, M A, Lu, Y, Sano, T, Fang, X, Tang, P, LaPushin, R, Koul, D, Bookstein, R, Stokoe, D, Yung, W K. 1998. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58:5285–90.Google ScholarPubMed

Davis, J M G, Beckett, S T, Bolton, R E, Collins, P, and Middleton, A P. 1978. Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer 37:673–88.CrossRefGoogle ScholarPubMed

Davison, A J. 2002. Evolution of the herpesviruses. Vet Microbiol 86:69–88.CrossRefGoogle ScholarPubMed

Davison, A J, Sauerbier, W, Dolan, A, Addison, C, and McKinnell, R G. 1999. Genomic studies of the Lucké tumor herpesvirus (RaHV-1). J Cancer Res Clin Oncol 125:232–8.CrossRefGoogle Scholar

Dawe C J. 1964. An appreciation of Dr. Mearl F Stanton. In: Use of small fish species in carcinogenecity testing. NCI Monograph 65:1–2.

Dawe C J. 1969. Phylogeny and oncogeny. In: Dawe, C J and Harshbarger, J C (eds.). Neoplasms and Related Disorders in Invertebrate and Lower Vertebrate Animals. Bethesda, MD: National Cancer Institute.Google Scholar

Dawe CJ. 1969. Phylogeny and oncogeny. In: Neoplasms and Related Disorders in Invertebrate and Lower Vertebrate Animals. Dawe, C J and Harshbarger, J C, eds, Bethesda: Natl Cancer Inst Monogr 31:1–40.Google Scholar

Dawe, C J, Harshbarger, J C, Kondo, S, Sugimura, T, and Takayama, S (eds.). 1981. Phyletic Approaches to Cancer. Tokyo: Japan Scientific Societies Press.Google Scholar

Dean, C, Chetty, U, and Forrest, A P M. 1983. Effects of immediate breast reconstruction on psychosocial morbidity after mastectomy. Lancet 1:459–62.CrossRefGoogle ScholarPubMed

DeCaprio, J A, Ludlow, J W, Figge, J, Shew, J-Y, Huang, C-M, Lee, W-H, Marsillo, E, Paucha, E, and Livingston, D M. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–83.CrossRefGoogle ScholarPubMed

DeGregori, J, Leone, G, Miron, A, Jakoi, L, and Nevins, J R. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245–50.CrossRefGoogle ScholarPubMed

Gruijl, F R, Longstreth, J, Norval, M, Cullen, A P, Slaper, H, Kripke, M L, Takizawa, Y, and Leun, J C. 2003. Health effects from stratospheric ozone depletion and interactions with climate change. Photochem Photobiol Sci 2:16–28.Google ScholarPubMed

Deininger, M W, Goldman, J M, Lydon, N, and Melo, J V. 1997. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 90:3691–8.Google ScholarPubMed

Jong, P J, Gorsovsky, A J, and Glickman, B W. 1988. Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: An analysis at the DNA sequence level. Proc Natl Acad Sci USA 85:3499–3503.CrossRefGoogle ScholarPubMed

Kernion, J B and Berry, D. 1980. The diagnosis and treatment of renal cell carcinoma. Cancer 45:1947–56.CrossRefGoogle Scholar

Demetri, G D. 2002. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571). Eur J Cancer 38 Suppl 5:S-52–59.CrossRefGoogle Scholar

Demetri, G D, Mehren, M, Blanke, C D, Abbeele, A D, Eisenberg, B, Roberts, P J, Heimrich, M C, Tuveson, D A, Singer, S, and Janicek, M. 2002. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–80.CrossRefGoogle ScholarPubMed

Demunter, A, Stas, M, Degreef, H, Wolf-Peeters, C, and Oord, J J. 2001. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol 117:1483–9.Google ScholarPubMed

Deng, T and Karin, M. 1994. C-Fos transcriptional activity stimulated by H-ras-activated protein kinase distinct from JNK and ERK. Nature 371:171–5.CrossRefGoogle ScholarPubMed

Der, C J, Finkel, T, and Cooper, G M. 1986. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell 44:167–76.CrossRefGoogle ScholarPubMed

Dérijard, B, Hibi, M, Wu, I-H, Barret, T, Su, B, Deng, T, Karin, M, and Davis, R J. 1994. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025–37.CrossRefGoogle ScholarPubMed

Devesa, S S, Graman, D J, Blot, W J, Pennello, G, Hoover, R N, and Fraumeni, J F Jr. 1999. Atlas of Cancer Mortality in the United States, 1954–94. Washington DC: US Govt Print Off (NIH) 99–4564.Google Scholar

DeVilliers, E-M. 1989. Heterogeneity of the human papillomavirus group. J Virol 53:4898–4903.Google Scholar

Vita, V T Jr, Hellman, S, and Rosenberg, S A, eds. 2004. Cancer: Principles and Practice of Oncology, 7th ed., Philadelphia, PA: Lippincott Williams and Wilkins.Google Scholar

Dexter, D L, Oki, T, and Heidelberger, C. 1973. Fluorinated pyrimidines. Xⅼⅱ. Effect of 5-trifluoromethyl-1-2′-deoxyuridine on transcription of vaccinia viral messenger ribonucleic acid. Mol Pharmacol 9:283–96.Google Scholar

DiBerardino, M A. 1997. Genomic Potential of Differentiated Cells. New York: Columbia University Press.Google Scholar

DiBerardino, M A and McKinnell, R G. 2004. The pathway to animal cloning and beyond – Robert Briggs (1911–1983) and Thomas J. King (1921–2000). J Exp Zool 301A:275–79.CrossRefGoogle Scholar

DiBerardino, M A, King, T J, and McKinnell, R G. 1963. Chromosome studies of a frog renal adenocarcinoma line carried by intraocular transplantation. J Natl Cancer Inst 31:769–89.Google ScholarPubMed

Dickson, M A, Hahn, W C, Ino, Y, Ronfard, V, Wu, J Y, Weinberg, R A, Louis, D N, Li, F P, and Rheinwald, J G. 2000. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20: 1436–47.CrossRefGoogle ScholarPubMed

Diffey, B L. 1987. Cosmetic solaria and malignancies of the skin. Photodermatology 4:273–6.Google Scholar

Di Fiore, P P, Pierce, J H, Kraus, M H, Segatto, O, King, C R, and Aaronson, S A. 1987. erbB-2 is a potent oncogene when overexpressed in NIH3T3 cells. Science 237:178–82.CrossRefGoogle Scholar

Dipple, A, Khan, Q A, Page, J E, Ponten, I, and Szeliga, J. 1999. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens (review). Int J Oncol 14:103–11.Google Scholar

Diwan, B A, Ohshima, M, and Rice, J M. 1989. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methylacetoxy-methylnitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors. Carcinogenesis 10:183–8.CrossRefGoogle ScholarPubMed

Dixon, F J and Moore, R A. 1952. Tumors of the male sex organs. Atlas of tumor pathology, section ⅷ, Fascicle 31b and 32. Washington, DC: Armed Forces Institute of Pathology.Google Scholar

Dobson, J M, Samuel, S, Milstein, H, Rogers, K, and Wood, J L. 2002. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. J Small Anim Pract 43:240–6.CrossRefGoogle ScholarPubMed

Dohner, K, Tobia, K, Ulrich, R, Frohling, S, Benner, A, Schlenk, R F, and Dohner, H. 2002. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 20:3254–61.CrossRefGoogle ScholarPubMed

Doll, R. 1967. Prevention of Cancer: Pointers from Epidemiology. London: The Nuffield Provincial Hospitals Trust.Google Scholar

Doll, R. 1992. Health and the environment in the 1990s. Am J Public Health 82:933–41.CrossRefGoogle ScholarPubMed

Doll, R and Bradford-Hill, A. 1950. Smoking and carcinoma of the lung. Br Med J 2:739–48.CrossRefGoogle ScholarPubMed

Doll, R and Peto, R. 1981. The causes of cancer. J Natl Cancer Inst 66:1191–1308.CrossRefGoogle Scholar

Doll, R, Peto, R, Boreham, J, and Sutherland, I. 2004. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328:1519–28.CrossRefGoogle ScholarPubMed

Doll, R, Peto, R, Wheatley, K, Gray, R, and Sutherland, I. 1994. Mortality in relation to smoking: 40-years' observations on male British doctors. BMJ 309:901–11.CrossRefGoogle ScholarPubMed

Donaldson, K L, Goolsby, G L, and Wahl, A F. 1994. Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle. Int J Cancer 57:847–55.CrossRefGoogle ScholarPubMed

Donehower, L A, Harvey, M, Slagle, B L, McArthur, M J, Montgomery, C A Jr, Butel, J S, and Bradley, A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–21.CrossRefGoogle ScholarPubMed

Dong, J-T, Lamb, P W, Rinker-Schaeffer, C W, Vukanovic, J, Ichikawa, T, Isaacs, J T, and Barrett, J C. 1995. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p112. Science 268:884–6.CrossRefGoogle Scholar

Dong, S, Geng, J P, Tong, J H, Wu, Y, Cai, J R, Sun, G L, Chen, S R, Wang, Z Y, Larsen, C J, Berger, R. 1993. Breakpoint clusters of the pml gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the pml-rara gene in a patient with t(15;17). Genes Chromosomes Cancer 6:133–9.CrossRefGoogle Scholar

Doniach, I and Pelc, S R. 1950. Autoradiographic techniques. Br J Radiol 23:184–92.CrossRefGoogle Scholar

Doniger, J, Jacobson, E D, Krell, K, and DiPaolo, J A. 1981. Ultraviolet light action spectra for neoplastic transformation and lethality of Syrian hamster embryo cells correlate with spectrum for pyrimidine dimer formation in cellular DNA. Proc Natl Acad Sci USA 78:2378–82.CrossRefGoogle ScholarPubMed

Doonan, J and Hunt, T. 1996. Why don't plants get cancer?Nature 380:481–2.CrossRefGoogle ScholarPubMed

Dorr, R T and Fritz, W L. 1980. Cancer Chemotherapy HandbookNew York: Elsevier.Google Scholar

Dorr, R T and Hoff, D. 1994. Cancer Chemotherapy Handbook. Norwalk, CT: Appleton and Lange.Google Scholar

Dotto, G P, Parada, L F, and Weinberg, R A. 1985. Specific growth response of ras-transformed fibroblasts to tumor promoters. Nature 318:472–5.CrossRefGoogle Scholar

Downward, J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11–22.CrossRefGoogle ScholarPubMed

Drenou, B, Fardel, O, Amiot, L, and Fauchet, R. 1993. Detection of P glycoprotein activity on normal and leukemic CD34+ cells. Leuk Res 17:1031–5.CrossRefGoogle ScholarPubMed

Driessens, M H, Stroeken, P J, Erena, N F, Valk, M A, Rijthoven, E A, and Roos, E. 1995. Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity. J Cell Biol 131:1849–55.CrossRefGoogle ScholarPubMed

Drinkwater, N R. 1990. Experimental models and biological mechanisms for tumor promotion. Cancer Cells 2:8–14.Google ScholarPubMed

Druckrey, H, Ivankovic, S, and Preussmann, R. 1966. Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210:1378–9.CrossRefGoogle ScholarPubMed

Druker, B J, Tamura, S, Buchdunger, E, Ohno, S, Segal, G M, Fanning, S, Zimmermann, J, and Lydon, N B. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561–6.CrossRefGoogle ScholarPubMed

Du, C, Fang, M, Li, Y, Li, L, and Wang, X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33–42.CrossRefGoogle ScholarPubMed

Dumaz, N and Marais, R 2003. Protein kinase A blocks Raf-1 activity by stimulating 14–3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem 278:29819–23.CrossRefGoogle ScholarPubMed

Dungan, C F, Hamilton, R M, Hudson, K L, McCollough, C B, and Reece, K S. 2002. Two epizootic diseases in Chesapeake Bay commercial clams, Mya arenaria and Tagelus plebeius. Dis Aquat Organ 50:67–78.CrossRefGoogle ScholarPubMed

Dunn, J E. 1975. Cancer epidemiology in populations of the United States – with emphasis on Hawaii and California – and Japan. Cancer Res 35:3240–5.Google ScholarPubMed

Dupont, E, Falardeau, P, Mousa, S A, Dimitriadou, V, Pepin, M C, Wang, T, and Alaoui-Jamali, M A. 2002. Antiangiogenic and antimetastatic properties of Neovastat (AE-941) an orally active extract derived from cartilage tissue. Clin Exp Metastasis 19:145–53.CrossRefGoogle ScholarPubMed

Dutreix, J, Tubiana, M, Wambersie, A, and Malaise, E. 1971. The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Eur J Cancer 7:205–13.CrossRefGoogle ScholarPubMed

Dworkin, H J, Meier, D A, and Kaplan, M. 1995. Advances in the management of patients with thyroid disease. Semin Nucl Med 25:205–20.CrossRefGoogle ScholarPubMed

Eardley, A M, Heller, G, and Warrell, R P Jr. 1994. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia. Leukemia 8:934–9.Google ScholarPubMed

Earle, J. 1808. Chirurgical works of Percivall Pott. A new edition with his last corrections to which are added a short account of the life of the author, a method of curing the hydrocele by injection and occasional notes and observations. London: J Johnson.Google Scholar

Easton, J, Wei, T, Lahti, J M, and Kidd, V J. 1998. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Cancer Res 58:2624–32.Google ScholarPubMed

Eferl, R and Wagner, E F. 2003. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859–68.CrossRefGoogle ScholarPubMed

Egeblad, M and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer 2:161–74.CrossRefGoogle ScholarPubMed

Egner, P A, Wang, J B, Zhu, Y R, Zhang, B C, Wu, Y, Zhang, Q N, Qian, G S, Kuang, S Y, Gange, S J, Jacobson, L P. 2001. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601–6.CrossRefGoogle ScholarPubMed

Ehrhardt, A, Ehrhardt, G R A, Guo, X, and Schrader, J W. 2002. Ras and relatives – job sharing and networking keep an old family together. Exp Hematol 30:1089–1106.CrossRefGoogle ScholarPubMed

Eichner, E R. 1987. Exercise, lymphokines, calories, and cancer. Physician Sportsmed 15:109–16.CrossRefGoogle ScholarPubMed

Einfeld, D A, Brown, J P, Valentine, M A, Clark, E A, and Ledbetter, J A. 1988. Molecular cloning of the human b cell cd20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 7:711–17.Google Scholar

el-Deiry, W S, Harper, J W, O'Connor, P M, Velculescu, V E, Canman, C E, Jackman, J, Pietenpol, J A, Burrell, M, Hill, D E, and Wang, Y. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169–74.Google ScholarPubMed

Elion, G B and Hitchings, G H. 1965. Metabolic basis for the actions of analogs of purines and pyrimidines. Adv Chemother 2:91–177.CrossRefGoogle ScholarPubMed

Elwood, J M, Lee, J A H, Walter, S D, Mo, T, and Green, A E S. 1974. Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada. Int J Epidemiol 3:325–32.CrossRefGoogle ScholarPubMed